Pearlify UI

Pearlify Data Viewer

read-only

홈 · 표

재무제표 주요계정

보고서별 핵심 계정(매출·이익·자산 등). 계정명은 공시 원문 그대로, 지표는 규칙으로 매핑합니다.

기술 정보 보기 (+11)
수집원발생값 ↓관측 가능 시각법인회사명사업연도기간연결구분재무제표계정명표준 지표금액기준일
dart-financials2025-11-142026-07-23 20:12:05—신한지주2,025Q3CFSIS영업이익(손실)—1.9조원2025-09-30
dart-financials2025-11-142026-07-23 20:12:05—신한지주2,025Q3CFSIS총포괄손익comprehensive_income1.3조원2025-09-30
dart-financials2025-11-142026-07-23 20:12:05—신한지주2,025Q3CFSIS순수수료손익—7680.6억원2025-09-30
dart-financials2025-11-142026-07-23 20:12:05—신한지주2,025Q3OFSBS자산총계total_assets38.4조원2025-09-30
dart-financials2025-11-142026-07-23 20:12:05—신한지주2,025Q3OFSBS부채총계total_liabilities11.3조원2025-09-30
dart-financials2025-11-142026-07-23 20:12:05—신한지주2,025Q3OFSBS자본금capital_stock2.9조원2025-09-30
dart-financials2025-11-142026-07-23 20:12:05—신한지주2,025Q3OFSBS이익잉여금retained_earnings8.2조원2025-09-30
dart-financials2025-11-142026-07-23 20:12:05—신한지주2,025Q3OFSBS자본총계total_equity27조원2025-09-30
dart-financials2025-11-142026-07-23 20:12:05—신한지주2,025Q3OFSIS법인세차감전 순이익pretax_income-470.7억원2025-09-30
dart-financials2025-11-142026-07-23 20:12:05—신한지주2,025Q3OFSIS당기순이익(손실)net_income-214.1억원2025-09-30
dart-financials2025-11-142026-07-23 20:12:05—신한지주2,025Q3OFSBS당기손익-공정가치측정금융자산—3.5조원2025-09-30
dart-financials2025-11-142026-07-23 20:12:05—신한지주2,025Q3OFSIS순이자손익—-612.5억원2025-09-30
dart-financials2025-11-142026-07-23 20:12:05—신한지주2,025Q3OFSIS이자수익—237.3억원2025-09-30
dart-financials2025-11-142026-07-23 20:12:05—신한지주2,025Q3OFSIS이자비용—849.8억원2025-09-30
dart-financials2025-11-142026-07-23 20:12:05—신한지주2,025Q3OFSIS영업이익(손실)—-467.1억원2025-09-30
dart-financials2025-11-142026-07-23 20:12:05—신한지주2,025Q3OFSIS총포괄손익comprehensive_income-214.1억원2025-09-30
dart-financials2025-11-142026-07-23 20:12:05—신한지주2,025Q3OFSIS순수수료손익—176.4억원2025-09-30
dart-financials2025-11-142026-07-23 20:12:06—삼성바이오로직스2,025Q3CFSBS유동자산current_assets6.3조원2025-09-30
dart-financials2025-11-142026-07-23 20:12:06—삼성바이오로직스2,025Q3CFSBS비유동자산non_current_assets11.9조원2025-09-30
dart-financials2025-11-142026-07-23 20:12:06—삼성바이오로직스2,025Q3CFSBS자산총계total_assets18.3조원2025-09-30
dart-financials2025-11-142026-07-23 20:12:06—삼성바이오로직스2,025Q3CFSBS유동부채current_liabilities3.7조원2025-09-30
dart-financials2025-11-142026-07-23 20:12:06—삼성바이오로직스2,025Q3CFSBS비유동부채non_current_liabilities2.3조원2025-09-30
dart-financials2025-11-142026-07-23 20:12:06—삼성바이오로직스2,025Q3CFSBS부채총계total_liabilities6.1조원2025-09-30
dart-financials2025-11-142026-07-23 20:12:06—삼성바이오로직스2,025Q3CFSBS자본금capital_stock1779.3억원2025-09-30
dart-financials2025-11-142026-07-23 20:12:06—삼성바이오로직스2,025Q3CFSBS이익잉여금retained_earnings6.3조원2025-09-30
dart-financials2025-11-142026-07-23 20:12:06—삼성바이오로직스2,025Q3CFSBS자본총계total_equity12.1조원2025-09-30
dart-financials2025-11-142026-07-23 20:12:06—삼성바이오로직스2,025Q3CFSIS매출액revenue1.6조원2025-09-30
dart-financials2025-11-142026-07-23 20:12:06—삼성바이오로직스2,025Q3CFSIS영업이익operating_income7288.4억원2025-09-30
dart-financials2025-11-142026-07-23 20:12:06—삼성바이오로직스2,025Q3CFSIS법인세차감전 순이익pretax_income7670억원2025-09-30
dart-financials2025-11-142026-07-23 20:12:06—삼성바이오로직스2,025Q3CFSIS당기순이익(손실)net_income5744.5억원2025-09-30
dart-financials2025-11-142026-07-23 20:12:06—삼성바이오로직스2,025Q3CFSIS총포괄손익comprehensive_income5766.2억원2025-09-30
dart-financials2025-11-142026-07-23 20:12:06—삼성바이오로직스2,025Q3OFSBS유동자산current_assets4.7조원2025-09-30
dart-financials2025-11-142026-07-23 20:12:06—삼성바이오로직스2,025Q3OFSBS비유동자산non_current_assets9.6조원2025-09-30
dart-financials2025-11-142026-07-23 20:12:06—삼성바이오로직스2,025Q3OFSBS자산총계total_assets14.4조원2025-09-30
dart-financials2025-11-142026-07-23 20:12:06—삼성바이오로직스2,025Q3OFSBS유동부채current_liabilities2.7조원2025-09-30
dart-financials2025-11-142026-07-23 20:12:06—삼성바이오로직스2,025Q3OFSBS비유동부채non_current_liabilities1.2조원2025-09-30
dart-financials2025-11-142026-07-23 20:12:06—삼성바이오로직스2,025Q3OFSBS부채총계total_liabilities4조원2025-09-30
dart-financials2025-11-142026-07-23 20:12:06—삼성바이오로직스2,025Q3OFSBS자본금capital_stock1779.3억원2025-09-30
dart-financials2025-11-142026-07-23 20:12:06—삼성바이오로직스2,025Q3OFSBS이익잉여금retained_earnings4.5조원2025-09-30
dart-financials2025-11-142026-07-23 20:12:06—삼성바이오로직스2,025Q3OFSBS자본총계total_equity10.4조원2025-09-30
dart-financials2025-11-142026-07-23 20:12:06—삼성바이오로직스2,025Q3OFSIS매출액revenue1.2조원2025-09-30
dart-financials2025-11-142026-07-23 20:12:06—삼성바이오로직스2,025Q3OFSIS영업이익operating_income6332.6억원2025-09-30
dart-financials2025-11-142026-07-23 20:12:06—삼성바이오로직스2,025Q3OFSIS법인세차감전 순이익pretax_income6627.4억원2025-09-30
dart-financials2025-11-142026-07-23 20:12:06—삼성바이오로직스2,025Q3OFSIS당기순이익(손실)net_income4964.7억원2025-09-30
dart-financials2025-11-142026-07-23 20:12:06—삼성바이오로직스2,025Q3OFSIS총포괄손익comprehensive_income4959.5억원2025-09-30
dart-financials2025-11-142026-07-23 20:12:07—LG에너지솔루션2,025Q3CFSIS매출액revenue5.6조원2025-09-30
dart-financials2025-11-142026-07-23 20:12:07—LG에너지솔루션2,025Q3CFSBS유동자산current_assets17.1조원2025-09-30
dart-financials2025-11-142026-07-23 20:12:07—LG에너지솔루션2,025Q3CFSBS비유동자산non_current_assets49.8조원2025-09-30
dart-financials2025-11-142026-07-23 20:12:07—LG에너지솔루션2,025Q3CFSBS자산총계total_assets67조원2025-09-30
dart-financials2025-11-142026-07-23 20:12:07—LG에너지솔루션2,025Q3CFSBS유동부채current_liabilities16.2조원2025-09-30
4,008건 중 2,401–2,450← 이전49 / 81 쪽다음 →

fundamental_facts · 컬럼 24개 · occurredAt desc 정렬